Literature DB >> 2666216

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

A Fontbonne1, E Eschwège, F Cambien, J L Richard, P Ducimetière, N Thibult, J M Warnet, J R Claude, G E Rosselin.   

Abstract

The Paris Prospective Study is a long-term investigation of the incidence of coronary heart disease in a large population of working men. The first follow-up examination involved 7,038 men, aged 43-54 years. Subjects with impaired glucose tolerance or diabetes (n = 943) were selected from the total population for a separate analysis of coronary heart disease mortality risk factors. During a mean follow-up of 11 years, 26 of these 943 subjects with abnormal glucose tolerance died from coronary heart disease. Univariate analysis showed that plasma triglyceride level (p less than 0.006), plasma cholesterol level (p less than 0.02), and plasma insulin level both fasting and 2-h post-glucose load (p less than 0.02), were significantly higher in subjects who died from coronary heart disease compared to those who did not. In multivariate regression analysis using the Cox model, plasma triglyceride level was the only factor positively and significantly associated with coronary death. The distribution of plasma triglyceride levels was clearly higher for the subjects who died from coronary heart disease compared to those who did not die from this cause or were alive at the end of the follow-up. This new epidemiological evidence that hypertriglyceridaemia is an important predictor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes suggests a possible role of dyslipidaemia in the excessive occurrence of atherosclerotic vascular disease in this category of subjects.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2666216     DOI: 10.1007/bf00265546

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  42 in total

1.  Hepatic insulin responsiveness in patients with endogenous hypertriglyceridaemia.

Authors:  R M Bernstein; B M Davis; J M Olefsky; G M Reaven
Journal:  Diabetologia       Date:  1978-04       Impact factor: 10.122

2.  Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

Authors:  M J Garcia; P M McNamara; T Gordon; W B Kannel
Journal:  Diabetes       Date:  1974-02       Impact factor: 9.461

3.  Separation of antibody-bound and unbound peptide hormones labelled with iodine-131 by talcum powder and precipitated silica.

Authors:  G Rosselin; R Assan; R S Yalow; S A Berson
Journal:  Nature       Date:  1966-10-22       Impact factor: 49.962

4.  [Practical considerations on semi-automatic estimation of triglycerides in the serum by fluorOMETRY (method of Kessler and Lederer). Comparison with the manual colorimetric method of Van Handel and Zilversmit].

Authors:  J R Claude; F Corre
Journal:  Ann Biol Clin (Paris)       Date:  1968 Mar-Apr       Impact factor: 0.459

5.  Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease--putative association via common antecedents; further evidence from the Whitehall Study.

Authors:  R J Jarrett; M J Shipley
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

6.  Plasma lipids and diabetes mellitus in an adult community.

Authors:  E Barrett-Connor; S M Grundy; M J Holdbrook
Journal:  Am J Epidemiol       Date:  1982-05       Impact factor: 4.897

7.  Hyperinsulinemia and hypertriglyceridemia, a vicious cycle with atherogenic potential.

Authors:  G Steiner; M Vranic
Journal:  Int J Obes       Date:  1982

8.  Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations.

Authors:  T A Welborn; K Wearne
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

9.  Plasma insulin and lipoprotein concentrations: an atherogenic association?

Authors:  T J Orchard; D J Becker; M Bates; L H Kuller; A L Drash
Journal:  Am J Epidemiol       Date:  1983-09       Impact factor: 4.897

10.  Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris Prospective Study.

Authors:  F Cambien; A Jacqueson; J L Richard; J M Warnet; P Ducimetiere; J R Claude
Journal:  Am J Epidemiol       Date:  1986-10       Impact factor: 4.897

View more
  83 in total

Review 1.  Postprandial lipemia and coronary risk.

Authors:  W Patsch; H Esterbauer; B Föger; J R Patsch
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

Review 2.  Hormone replacement therapy in postmenopausal women with diabetes mellitus: a risk-benefit assessment.

Authors:  B Andersson
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

Review 3.  Management of diabetic nephropathy.

Authors:  L Foggensteiner; S Mulroy; J Firth
Journal:  J R Soc Med       Date:  2001-05       Impact factor: 5.344

4.  Association of plasma triglyceride and C-peptide with coronary heart disease in Japanese-American men with a high prevalence of glucose intolerance.

Authors:  R W Bergstrom; D L Leonetti; L L Newell-Morris; W P Shuman; P W Wahl; W Y Fujimoto
Journal:  Diabetologia       Date:  1990-08       Impact factor: 10.122

Review 5.  Maternal micronutrient restriction programs the body adiposity, adipocyte function and lipid metabolism in offspring: a review.

Authors:  K Rajender Rao; I J N Padmavathi; M Raghunath
Journal:  Rev Endocr Metab Disord       Date:  2012-06       Impact factor: 6.514

6.  The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients.

Authors:  R W James; D Pometta
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

7.  Antioxidant and antihyperlipidaemic activity of protocatechuic acid on streptozotocin-diabetic rats.

Authors:  Ranganathan Harini; Kodukkur Viswanathan Pugalendi
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

8.  Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba.

Authors:  K Hall; J Murrell; A Ogunniyi; M Deeg; O Baiyewu; S Gao; O Gureje; J Dickens; R Evans; V Smith-Gamble; F W Unverzagt; J Shen; H Hendrie
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

Review 9.  Coronary heart disease in diabetes mellitus--antecedents and associations.

Authors:  P H Winocour
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

Review 10.  Specific lipid lowering therapy in the management of diabetes.

Authors:  P N Durrington
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.